Showing 501 - 520 results of 526 for search '"United States of America"', query time: 0.11s Refine Results
  1. 501
  2. 502
  3. 503

    COVID-19 pandemic and vaccination rate in patients with psoriasis treated with biologics: A single center experience by Milčić Danijela, Malinić Marija, Ćirković Anđa, Krupniković Doroteja, Milinković-Srećković Mirjana

    Published 2024-01-01
    “…Even though there was no data at the beginning of the pandemic on the efficacy and safety of vaccines against COVID-19 in patients with psoriasis treated with biologics, the National Psoriasis Foundation (United States of America) recommended vaccination in these patients. …”
    Get full text
    Article
  4. 504

    Leveraging machine learning to uncover multi-pathogen infection dynamics across co-distributed frog families by Daniele L. F. Wiley, Kadie N. Omlor, Ariadna S. Torres López, Celina M. Eberle, Anna E. Savage, Matthew S. Atkinson, Lisa N. Barrow

    Published 2025-01-01
    “…Methods We selected 12 widespread and abundant focal taxa within three ecologically distinct, co-distributed host families (Bufonidae, Hylidae, and Ranidae) and sampled them across the eastern two-thirds of the United States of America. We screened and quantified infection loads via quantitative PCR for three major pathogens: the fungal pathogen Batrachochytrium dendrobatidis (Bd), double-stranded viruses in the lineage Ranavirus (Rv), and the alveolate parasite currently referred to as Amphibian Perkinsea (Pr). …”
    Get full text
    Article
  5. 505

    Is Intra-articular Platelet-rich Plasma Injection Safe and Effective in Osteoarthritis Knee? A Prospective Study: A Case Series by R Sahaya Jose, N Kattu Bava, M Syed Moosa

    Published 2024-01-01
    “…IBM Chicago city, Illinois state, United States of America) version 20.0. Results: We have excellent improvement in VAS score from the mean value of 7.5 ± 2 initially at preinjection to 4.5 ± 1.5 after 6 months follow-up and WOMAC score from 74.5 ± 8.5 initially at preinjection to 55.5 ± 10.5 after 6 months follow-up. …”
    Get full text
    Article
  6. 506
  7. 507

    A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness. by Matthew R Dunn, Didong Li, Marc A Emerson, Caroline A Thompson, Hazel B Nichols, Sarah C Van Alsten, Mya L Roberson, Stephanie B Wheeler, Lisa A Carey, Terry Hyslop, Jennifer Elston Lafata, Melissa A Troester

    Published 2024-12-01
    “…The main limitations of this work were inability to make inferences about causal effects of individual variables that formed the latent classes, reliance on self-reported socioeconomic and healthcare history information, and generalizability outside of North Carolina, United States of America.<h4>Conclusions</h4>Black patients face more frequent delays throughout the care continuum, likely stemming from different types of access barriers at key junctures. …”
    Get full text
    Article
  8. 508
  9. 509

    Review of the Handbook of Accounting, Accountability and Governance edited by Garry D. Carnegie and Christopher J. Napier by Anna Szychta

    Published 2024-12-01
    “…The authors come from various countries, including the United Kingdom and Ireland, Australia and New Zealand, some Western countries of continental Europe (Finland, Germany, Italy, Portugal, and Spain), as well as Canada, the United States of America, and Saudi Arabia. The general thesis of the entire collection of chapters is that “accounting, accountability and governance go beyond being technical practices to be learned, adopted and repeated, and must be studied as social and moral practices.” …”
    Get full text
    Article
  10. 510
  11. 511
  12. 512
  13. 513
  14. 514
  15. 515
  16. 516

    Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process by Breanne Stewart, Pirkko Lepola, Gunter F. Egger, Fahimeda Ali, Albert J. Allen, Albert J. Allen, Alysha K. Croker, Andrew J. Davidson, Pamela Dicks, Saul N. Faust, Saul N. Faust, Dionna Green, Collin Hovinga, Collin Hovinga, Agnes V. Klein, Robyn Langham, Hidefumi Nakamura, Laura Pioppo, Shiva Ramroop, Michiyo Sakiyama, Isabel Sanchez Vigil de la Villa, Junko Sato, Donna L. Snyder, Mark A. Turner, Mark A. Turner, Sarah Zaidi, Kanecia Zimmerman, Kanecia Zimmerman, Thierry Lacaze-Masmonteil

    Published 2025-02-01
    “…This work, undertaken by the Working Group (WG) on International Collaborations at the European Network of Pediatric Research at the European Medicines Agency (Enpr-EMA) aims to describe the research ethics review requirements including any pediatric specific requirements, as well as current or upcoming changes across six jurisdictions – the European Union (EU), United Kingdom (UK), United States of America (USA), Canada, Japan, and Australia.MethodsAn open questionnaire developed by the WG and directed at both the Competent Authorities (CA) and the national pediatric clinical trial networks arranged by jurisdictions.ResultsA synopsis of the current regulatory requirements covers centralized versus independent review, comparisons between investigator initiated and industry sponsored clinical trials, timelines, review board members requirements and the consenting/assent process for clinical trial (CT) applications, application submission processes and application requirements for each of the six jurisdictions. …”
    Get full text
    Article
  17. 517
  18. 518
  19. 519
  20. 520

    A Study on the Genotype × Environment Interaction in Promising Advanced Genotypes of Soybean using Graphical GGE-biplot Analysis by Bahram Masoudi, Amir Gholizadeh, Parastoo Majidian, Ebrahim Hezarjaribi, Nasrin Razmi, Farnaz Shariati

    Published 2024-11-01
    “…Soybean has been the food of Asian people, especially China, for centuries, and Chinese people consume it along with rice as their main food. The United States of America is the largest producer of soybeans and produces almost two-thirds of the world's crop. …”
    Get full text
    Article